Skip to content
naulon
Not checkedNot checked for notices yet.

Recurrent alveolar hemorrhage: How do you treat that which you cannot see?

Philipose Jobin, Siddiqui Faraz, Wong Jiyoung and 3 more

Respiratory Medicine Case Reports · 2018

doi:10.1016/j.rmcr.2018.09.002 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Diffuse alveolar hemorrhage (DAH) is a rare and life-threatening event which is characterized by bleeding into the alveolar spaces of the lung. Etiology of DAH can be broadly divided into immune and non-immune mediated disease. In the absence of infection or malignancy, an immunological workup is required to find the cause of alveolar bleed. Rarely, there is a failure to establish a definitive etiology in patients with DAH. In those scenarios, patients who do not respond to steroids, plasmapheresis should be considered as a rescue treatment to prevent catastrophic outcomes. Herein, we present a unique case of a 48-year-old male admitted with DAH of unknown etiology completely recovered after empirical plasmapheresis.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.